Skip to main content
. Author manuscript; available in PMC: 2009 Oct 12.
Published in final edited form as: Handb Exp Pharmacol. 2009;(190):403–418. doi: 10.1007/978-3-540-79885-9_20

Fig. 7.

Fig. 7

(a) Time line of initial study of AdhAQP1 efficacy in irradiated rats. Rats were irradiated on day zero with either 17.5 Gy or 21 Gy, or sham-irradiated. After 90 (17.5 Gy) or 120 (21 Gy) days, AdhAQP1 or a control vector (Addl312) was administered to both submandibular glands and 3 days later saliva was collected. (b) Function of transgenic hAQP1 in vivo. Salivary flow rates obtained in animals irradiated (17.5 Gy) or not, and administered either AdhAQP1 or Addl312. Rats administered Addl312 are shown in the hatched bars, while rats administered AdhAQP1 are shown in the black bars. The results are expressed as saliva secretion in microliters per 100 g body weight per 15 min and are mean values ± SEMs. This figure originally was published as Fig. 4b in (Delporte et al. 1997)